Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth

Original Submission
30 Sep 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
1 Nov 2024 Author responded Author comments - Marina Rogova
Resubmission - Version 4
1 Nov 2024 Submitted Manuscript version 4
15 Nov 2024 Author responded Author comments - Marina Rogova
Resubmission - Version 5
15 Nov 2024 Submitted Manuscript version 5
30 Dec 2024 Reviewed Reviewer Report
30 Dec 2024 Reviewed Reviewer Report
13 Mar 2025 Author responded Author comments - Marina Rogova
Resubmission - Version 6
13 Mar 2025 Submitted Manuscript version 6
Publishing
19 Mar 2025 Editorially accepted
3 Apr 2025 Article published 10.1186/s12876-025-03804-3

You can find further information about peer review here.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us